10x Genomics, Inc. is trading 2.4% down at $30.30, extending last week’s pullback after a sharp multi-day rally into early June.
- The stock fell approximately 7% on June 5 due to profit-taking and mean reversion following a one-third rebound from late May lows.
- With no fresh company-specific headlines or analyst updates this morning, the move appears to be a technical continuation of the recent correction despite a modestly positive broader market.